PTSD Trial, Recruiting NCT05929911 Sponsor: Montefiore Medical Center Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05929911
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with PTSD (post-traumatic stress disorder) according to a standardised clinical assessment, with a symptom severity score of 25 or above on that assessment
  • People who have been diagnosed with HIV, confirmed through medical records or HIV testing
  • People who have been on the same psychiatric or mental health medications for at least 2 months before joining, and who are expected to stay on that same medication throughout the trial

Who may not be able to join:

  • People who have a condition involving psychosis (such as hearing or seeing things that others do not, or losing touch with reality)
  • People who have been diagnosed with Bipolar I disorder
  • People who are currently experiencing serious thoughts of suicide or self-harm
  • People who are currently dealing with a substance use disorder (such as alcohol or drug dependence)
  • People who have an organic mental syndrome (a brain condition caused by a physical or medical issue) or an intellectual disability
  • People who have unstable medical conditions unrelated to HIV

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Barbara Milrod, MD, Montefiore Medical Center

Phone: 703-981-7184

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Montefiore Medical Center
Registry
ClinicalTrials.gov
Start date
26 April 2024
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in PTSD Score based on the Clinician Administered PTSD Scale for DSM-5; Change in PTSD Score based on the Clinician Administered PTSD Scale for DSM-5; Change in PTSD Score based on the Clinician Administered PTSD Scale for DSM-5; Change in PTSD Score based on the Clinician Administered PTSD Scale for DSM-5

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov